The Forgotten Ebola Vaccine Ready for Action

A groundbreaking Ebola vaccine developed in 2011 by Thomas Geisbert, proven 100% effective in monkeys against the deadly Bundibugyo strain, sits unused on the shelf—despite being the WHO’s top candidate for the current outbreak in DRC and Uganda. Created originally as a biodefense project post-9/11, the vaccine was sidelined due to lack of commercial interest until the 2013-2016 West Africa epidemic spurred global investment. Now, CEPI is funding human trials, hoping to deploy it before the next outbreak—because scientists know this strain will return. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3ab6f00717700492